1. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive
episode. BMC Med 2011;9:90.
2. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex
and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
3. Doris A, Ebmeier K, Shajahan P. Depressive illness. Lancet 1999;354:
1369-1375.
4. Miller WR. Psychological deficit in depression. Psychol Bull 1975;82:
238-260.
5. Bora E, Harrison BJ, Yücel M, Pantelis C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2013;
43:2017-2026.
6. Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA. A metaanalysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord 2012;140:113-124.
7. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a metaanalysis and review. Psychol Bull 2013;139:81-132.
8. Trivedi MH, Greer TL. Cognitive dysfunction in unipolar depression:
implications for treatment. J Affect Disord 2014;152-154:19-27.
9. Wagner S, Doering B, Helmreich I, Lieb K, Tadić A. A meta-analysis
of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant
treatment. Acta Psychiatr Scand 2012;125:281-292.
10. Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits
and disability in major depressive disorder. Psychiatry Res 2006;145:
39-48.
11. Kiosses DN, Alexopoulos GS. IADL functions, cognitive deficits, and severity of depression: a preliminary study. Am J Geriatr Psychiatry 2005;
13:244-249.
12. Westheide J, Quednow BB, Kuhn KU, Hoppe C, Cooper-Mahkorn D,
Hawellek, et al. Executive performance of depressed suicide attempters: the role of suicidal ideation. Eur Arch Psychiatry Clin Neurosci
2008;258:414-421.
13. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829.
14. Lorenzetti V, Allen NB, Fornito A, Yücel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI
studies. J Affect Disord 2009;117:1-17.
15. Rogers MA, Kasai K, Koji M, Fukuda R, Iwanami A, Nakagome K, et
al. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res
2004;50:1-11.
16. Cox SR, Ferguson KJ, Royle NA, Shenkin SD, MacPherson SE, MacLullich AM, et al. A systematic review of brain frontal lobe parcellation techniques in magnetic resonance imaging. Brain Struct Funct
2014;219:1-22.
www.psychiatryinvestigation.org 811
Temporal Activation Correlates Motor speed in MDD
17. Erickson LC, Rauschecker JP, Turkeltaub PE. Meta-analytic connectivity modeling of the human superior temporal sulcus. Brain Struct Funct
2017;222:267-285.
18. Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev
Neurosci 2004;27:279-306.
19. Szczepanski SM, Knight RT. Insights into human behavior from lesions
to the prefrontal cortex. Neuron 2014;83:1002-1018.
20. Hirosawa R, Narumoto J, Sakai Y, Nishida S, Ishida T, Nakamae T, et
al. Reduced dorsolateral prefrontal cortical hemodynamic response in
adult obsessive-compulsive disorder as measured by near-infrared
spectroscopy during the verbal fluency task. Neuropsychiatr Dis Treat
2013;9:955-962.
21. Kameyama M, Fukuda M, Yamagishi Y, Sato T, Uehara T, Ito M, et al.
Frontal lobe function in bipolar disorder: a multichannel near-infrared
spectroscopy study. Neuroimage 2006;29:172-184.
22. Matsuo K, Taneichi K, Matsumoto A, Ohtani T, Yamasue H, Sakano Y, et
al. Hypoactivation of the prefrontal cortex during verbal fluency test in
PTSD: a near-infrared spectroscopy study. Psychiatry Res 2003;124:1-10.
23. Matsuo K, Onodera Y, Hamamoto T, Muraki K, Kato N, Kato T. Hypofrontality and microvascular dysregulation in remitted late-onset
depression assessed by functional near-infrared spectroscopy. Neuroimage 2005;26:234-242.
24. Suto T, Fukuda M, Ito M, Uehara T, Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain
activation study. Biol Psychiatry 2004;55:501-511.
25. Boas DA, Dale AM, Franceschini, MA. Diffuse optical imaging of
brain activation: approaches to optimizing image sensitivity, resolution, and accuracy. Neuroimage 2004;23:S275-288.
26. Strangman G, Boas DA, Sutton JP. Non-invasive neuroimaging using
near-infrared light. Biol Psychiatry 2002;52:679-693.
27. Tomioka H, Yamagata B, Kawasaki S, Pu S, Iwanami A, Hirano J, et al.
A longitudinal functional neuroimaging study in medication-naïve depression after antidepressant treatment. PLoS One 2015;10:e0120828.
28. Takizawa R, Fukuda M, Kawasaki S, Kasai K, Mimura M, Pu S, et al.
Neuroimaging-aided differential diagnosis of the depressive state.
Neuroimage 2014;85:498-507.
29. Liu X, Sun G, Zhang X, Xu B, Shen C, Shi L, et al. Relationship between the prefrontal function and the severity of the emotional symptoms during a verbal fluency task in patients with major depressive
disorder: a multi-channel NIRS study. Prog Neuropsychopharmacol
Biol Psychiatry 2014;54:114-121.
30. Noda T, Yoshida S, Matsuda T, Okamoto N, Sakamoto K, Koseki S, et
al. Frontal and right temporal activations correlate negatively with depression severity during verbal fluency task: a multi-channel near-infrared spectroscopy study. J Psychiatr Res 2012;46:905-912.
31. Pu S, Matsumura H, Yamada T, Ikezawa S, Mitani H, Adachi A, et al.
Reduced frontopolar activation during verbal fluency task associated
with poor social functioning in late-onset major depression: multichannel near-infrared spectroscopy study. Psychiatry Clin Neurosci
2008;62:728-737.
32. Pu S, Nakagome K, Yamada T, Yokoyama K, Matsumura H, Mitani H,
et al. The relationship between the prefrontal activation during a verbal fluency task and stress-coping style in major depressive disorder: a
near-infrared spectroscopy study. J Psychiatr Res 2012;46:1427-1434.
33. Ikeda E, Shiozaki K, Ikeda H, Suzuki M, Hirayasu Y. Prefrontal dysfunction in remitted depression at work reinstatement using near-infrared spectroscopy. Psychiatry Res 2013;214:254-259.
34. Koseki S, Noda T, Yokoyama S, Kunisato Y, Ito D, Suyama H, et al. The
relationship between positive and negative automatic thought and activity in the prefrontal and temporal cortices: a multi-channel near-infrared spectroscopy (NIRS) study. J Affect Disord 2013;151:352-359.
35. Tsujii N, Mikawa W, Akashi H, Tsujimoto E, Adachi T, Kirime E, et al.
Right temporal activation differs between melancholia and nonmelancholic depression: a multichannel near-infrared spectroscopy study. J
Psychiatr Res 2014;55:1-7.
812
Psychiatry Investig 2020;17(8):804-813
36. Tsujii N, Mikawa W, Tsujimoto E, Adachi T, Niwa A, Ono H, et al. Reduced left precentral regional responses in patients with major depressive disorder and history of suicide attempts. PLoS One 2017;12:
e0175249.
37. American Psychiatric Association. Diagnostic and Statistical Manual
of Mental Disorders (5th Ed). Washington, D.C.: American Psychiatric
Publishing; 2013.
38. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
39. Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry
Clin Neurosci 2015;69:440-447.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
41. Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y. Estimation of premorbid IQ in individuals with Alzheimer’s disease using Japanese
ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 2006;60:332-339.
42. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L.
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
Schizophr Res 2004;68:283-297.
43. Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T.
Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 2007;61:602-609.
44. Pu S, Setoyama S, Noda T. Association between cognitive deficits and
suicidal ideation in patients with major depressive disorder. Sci Rep
2017;7:11637.
45. Hidese S, Ota M, Wakabayashi C, Noda T, Ozawa H, Okubo T, et al. Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiatr 2017;29:72-79.
46. Hidese S, Ota M, Matsuo J, Ishida I, Hiraishi M, Yoshida S, et al. Association of obesity with cognitive function and brain structure in patients
with major depressive disorder. J Affect Disord 2018;225:188-194.
47. Yamashita Y, Maki A, Ito Y, Watanabe E, Koizumi H. Noninvasive
near-infrared topography of human brain activity using intensity
modulation spectroscopy. Opt Eng 1996;35:1046-1049.
48. Toronov V, Webb A, Choi JH, Wolf M, Michalos A, Gratton E, et al.
Investigation of human brain hemodynamics by simultaneous nearinfrared spectroscopy and functional magnetic resonance imaging.
Med Phys 2001;28:521-527.
49. Okada E, Delpy DT. Near-infrared light propagation in an adult head
model. II. Effect of superficial tissue thickness on the sensitivity of the
near-infrared spectroscopy signal. Appl Opt 2003;42:2915-2922.
50. Singh AK, Okamoto M, Dan H, Jurcak V, Dan I. Spatial registration of
multichannel multi-subject fNIRS data to MNI space without MRI.
Neuroimage 2005;27:842-851.
51. Tsuzuki D, Jurcak V, Singh AK, Okamoto M, Watanabe E, Dan I. Virtual spatial registration of stand-alone fNIRS data to MNI space. Neuroimage 2007;34:1506-1518.
52. Shattuck DW, Mirza M, Adisetiyo V, Hojatkashani C, Salamon G, Narr
KL, et al. Construction of a 3D probabilistic atlas of human cortical
structures. Neuroimage 2007;39:1064-1080.
53. Takizawa R, Kasai K, Kawakubo Y, Marumo K, Kawasaki S, Yamasue
H, et al. Reduced frontopolar activation during verbal fluency task in
schizophrenia: a multi-channel near-infrared spectroscopy study.
Schizophr Res 2008;99:250-262.
54. Strangman G, Culver JP, Thompson JH, Boas DA. A quantitative comparison of simultaneous BOLD fMRI and NIRS recordings during
functional brain activation. Neuroimage 2002;17:719-731.
55. Singh AK, Dan I. Exploring the false discovery rate in multichannel
NIRS. Neuroimage 2006;33:542-549.
56. Gorwood P1, Corruble E, Falissard B, Goodwin GM. Toxic effects of
depression on brain function: impairment of delayed recall and the
cumulative length of depressive disorder in a large sample of depressed
outpatients. Am J Psychiatry 2008:165:731-739.
T Kiriyama et al.
57. Kiernan JA. Anatomy of the temporal lobe. Epilepsy Res Treat 2012;
2012:176157.
58. Pirmoradi M, Jemel B, Gallagher A, Tremblay J, D’Hondt F, Nguyen
DK, et al. Verbal memory and verbal fluency tasks used for language
localization and lateralization during magnetoencephalography. Epi-
lepsy Res 2016;119:1-9.
59. Tankus A, Fried I. Visuomotor coordination and motor representation
by human temporal lobe neurons. J Cogn Neurosci 2012;24:600-610.
60. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994;35:929-934.
www.psychiatryinvestigation.org 813
Supplementary Table 1. Correlations between mean oxy-Hb changes and demographic or clinical variables
Correlation analysis
Pearson
Spearman
Clinical variables
Correlation coefficient
p value
Age
-0.454 to 0.426
0.078 to 0.974
Estimated IQ
-0.440 to 0.328
0.116 to 1.000
Years of educations
-0.348 to 0.348
0.170 to 1.000
HAM-D score
-0.200 to 0.681
0.003 to 0.990
Illness duration
-0.465 to 0.479
0.070 to 0.994
Duration of depressive episodes
-0.263 to 0.471
0.076 to 0.990
Task performance
-0.473 to 0.183
0.048 to 0.988
Imipramine dose
-0.493 to 0.258
0.052 to 0.987
Chlorpromazine dose
-0.411 to 0.200
0.144 to 1.000
Diazepam dose
-0.321 to 0.263
0.225 to 1.000
oxy-Hb: oxygenated hemoglobin, IQ: intelligence quotient, HAM-D: 17-item Hamilton Rating Scale for Depression
Supplementary Table 2. Correlations between mean oxy-Hb changes and the other five BACS-J subscale scores
Correlation analysis
Pearson
Spearman
Correlation coefficient
p value
Verbal memory
Clinical variables
-0.641 to 0.497
0.010 to 0.977
Verbal fluency
-0.612 to 0.552
0.009 to 0.985
Attention and speed of information processing
-0.554 to 0.276
0.032 to 0.994
Executive function
-0.418 to 0.335
0.121 to 0.989
Working memory
-0.447 to 0.383
0.063 to 0.965
oxy-Hb: oxygenated hemoglobin, BACS-J: Japanese version of the Brief Assessment of Cognition in Schizophrenia
...